UTHR

United Therapeutics Corporation NMS · UTHR

$535.67 +6.62 (+1.25%)

Pullback · -0.56σ Grade C

+ Compare Open in Sniper

Valuation

Market cap $22.7B

P/E (ttm) 19.8

Forward P/E 16.2

Beta (5y) 0.58

Shares out 42.4M

Div yield —

Profitability & returns

ROE 20.3%

Net margin 40.6%

FCF margin 17.9%

Debt / equity —

Trading information

Last price $535.67

Day range $528.39 – $543.56

52-wk range $455.63 – $609.35

Avg volume 0.5M

RSI (2) 69.6

Trend zone Pullback

52-week range · today's price

$455.63$609.35

Company

Sector Healthcare

Industry Drug Manufacturers - Specialty & Generic

Exchange NMS

Next earnings 2026-07-29

United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat p…